Inventor · disambiguated record
Bart M. Remmerie
Also filed as: REMMERIE BART · REMMERIE BART M · REMMERIE BART M M
23 granted patents·5 pending applications·152 citations·filing 2010–2019
94Inventor score
Top patents by PatentIndex Score
28 records- 0196US9611332B2Antibodies to aripiprazole haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 4, 2017·18 cites·7 claims
- 0296US9494607B2Antibodies to aripiprazole and use thereofORTHO CLINICAL DIAGNOSTICS INC·Filed 2013·Granted Nov 15, 2016·17 cites·23 claims
- 0395US9795685B2Haptens of aripiprazoleJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Oct 24, 2017·17 cites·44 claims
- 0495US9410972B2Antibodies to quetiapine and use thereofORTHO CLINICAL DIAGNOSTICS INC·Filed 2013·Granted Aug 9, 2016·17 cites·20 claims
- 0594US9494608B2Antibodies to olanzapine and use thereofORTHO CLINICAL DIAGNOSTICS INC·Filed 2013·Granted Nov 15, 2016·15 cites·25 claims
- 0692US9850318B2Antibodies to quetiapine haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Dec 26, 2017·16 cites·15 claims
- 0792US9504682B2Haptens of aripiprazoleJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Nov 29, 2016·17 cites·13 claims
- 0891US9303041B2Haptens of olanzapineJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 5, 2016·17 cites·29 claims
- 0991US9304126B2Haptens of quetiapineJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 5, 2016·17 cites·21 claims
- 1078US10175257B2Antibodies to aripiprazole and use thereofJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jan 8, 2019·1 cites·19 claims
- 1172US11105793B2Antibodies to aripiprazole haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Aug 31, 2021·0 cites·11 claims
- 1271US11046786B2Antibodies to olanzapine and use thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jun 29, 2021·0 cites·20 claims
- 1371US10816561B2Antibodies to aripiprazole and use thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Oct 27, 2020·0 cites·26 claims
- 1470US2021017294A9Antibodies to quetiapine haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 1569US2019271712A1Antibodies to quetiapine and use thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 1666US10488401B2Antibodies to aripiprazole haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Nov 26, 2019·0 cites·15 claims
- 1764US10712353B2Antibodies to olanzapine haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jul 14, 2020·0 cites·7 claims
- 1863US11104742B2Antibodies to quetiapine and use thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Aug 31, 2021·0 cites·21 claims
- 1963US10379105B2Antibodies to aripiprazole haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Aug 13, 2019·0 cites·8 claims
- 2062US11226345B2Antibodies to olanzapine haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jan 18, 2022·0 cites·15 claims
- 2159US10465013B2Antibodies to quetiapine haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Nov 5, 2019·0 cites·14 claims
- 2259US10288631B2Antibodies to quetiapine and use thereofJANSSEN PHARMACEUTICA NV·Filed 2016·Granted May 14, 2019·0 cites·12 claims
- 2359US10166296B2Haptens of aripiprazoleJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jan 1, 2019·0 cites·9 claims
- 2458US10344098B2Antibodies to olanzapine and use thereofJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jul 9, 2019·0 cites·25 claims
- 2557US10435478B2Antibodies to quetiapine and use thereofJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Oct 8, 2019·0 cites·25 claims
- 2656US2014057303A1Antibodies to Olanzapine Haptens and Use ThereofJANSSEN PHARMACEUTICA NV·Filed 2013·Application pending·0 cites
- 2746US2013331402A1Dosing regimen associated with long-acting injectable paliperidone estersJANSSEN PHARMACEUTICA NV·Filed 2013·Application pending·0 cites
- 2838US2011105536A1Dosing regimen associated with long-acting injectable paliperidone estersLEWYN-BRISCOE PETER H·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bart M. Remmerie files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →